Hepatic Fibrosis: From Pathogenesis to Clinical Management
A special issue of Livers (ISSN 2673-4389).
Deadline for manuscript submissions: closed (20 October 2021) | Viewed by 14941
Special Issue Editor
Interests: liver diseases; biomakrer; cellular signaling; cytokines; chemokines; food products; vitamin A; weight loss; diet; fats; carbohydrates; supplements
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Liver fibrosis is a major challenge of global health. It occurs after repetitive or long-lasting injury to the liver and is characterized by excessive formation and deposition of fibrous connective tissue and architectural tissue remodeling. Although the molecular and cellular mechanisms contributing to the pathogenesis of liver fibrosis are well understood, pharmacological intervention targeting its progression is complicated and often only effective in experimental models. In this Special issue of Livers, I invite you to contribute original and cutting-edge research articles, reviews, shorter perspectives, or letters related to the theme of “Hepatic Fibrosis: From Pathogenesis to Clinical Management”.
In particular, expert articles reporting new mechanistic or general aspects of hepatic fibrogenesis are highly welcome. Relevant topics include but are not limited to: extracellular matrix, fibrotic signaling, immunomodulation, novel or improved experimental models, relevant cytokines/chemokines, inflammatory triggers, NASH, NAFLD, ASH, hepatitis, genetic predisposition, microbiota, bioimaging, therapeutic perspectives, and translational aspects.
Prof. Dr. Ralf Weiskirchen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Livers is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Liver fibrosis
- Hepatic stellate cells/myofibroblasts
- NASH/NAFLD/ASH
- Extracellular matrix
- Cholestasis
- Hepatitis
- Bile salts
- Inflammation
- Cytokines/chemokines
- Therapy